Global Wholehealth Partners Corporation was granted the rights from Nunzia Pharmaceutical Inc. to distribute and sell the Johnson & Johnson COVID-19 Vaccine (Vaccine). The Company will serve as a broker for Nunzia and follow the same sales order processing as used by Nunzia in connection with the distribution and sale of the Vaccine.
Global WholeHealth Partners Corporation
Equities
GWHP
US37959N1028
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | 0.00% | -99.00% |
2022 | Global WholeHealth Partners Corporation Reports Earnings Results for the Full Year Ended June 30, 2022 | CI |
2022 | Global WholeHealth Partners Corporation Auditor Raises 'Going Concern' Doubt | CI |
1st Jan change | Capi. | |
---|---|---|
-99.00% | 143 | |
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 68.11B | |
+2.39% | 50.53B | |
+9.36% | 44.8B | |
+2.70% | 40.7B | |
+24.51% | 32.3B | |
+3.43% | 26.53B | |
-0.32% | 24.96B |
- Stock Market
- Equities
- GWHP Stock
- News Global WholeHealth Partners Corporation
- Global Wholehealth Partners Corporation Grants the Rights from Nunzia Pharmaceutical Inc. to Distribute and Sell the Johnson & Johnson Covid-19 Vaccine